Trial Profile
(V01-118A-03) A Phase 3, Multicenter, Open-Label Study to Evaluate the Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Tazarotene/ulobetasol (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions
- 25 Nov 2015 New trial record